Registered Nurse in Hot Springs, SD Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Ms. Lori Dunn, Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 1501 Detroit Ave, Hot Springs, SD 57747 Phone: 720-988-3132 |
Andrea Michelle Sterkel, MSN-CNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1201 Highway 71 S, Hot Springs, SD 57747 Phone: 605-745-8910 |
Lori Mae Boggs, RN, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 500 N 5th St, Hot Springs, SD 57747 Phone: 605-745-2000 |
 James E Williams, RN Registered Nurse - Emergency Medicare: Not Enrolled in Medicare Practice Location: 1201 Highway 71 S, Hot Springs, SD 57747 Phone: 605-745-8910 |
Tanna Jean White, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1201 Highway 71 S, Hot Springs, SD 57747 Phone: 605-745-3159 |
News Archive
Cameron Health's PMA application for S-ICD System submitted to FDA
Cameron Health, Inc. announced today that it has submitted the Premarket Approval application to the Food and Drug Administration for the S-ICD System, the world's only completely subcutaneous implantable defibrillator.
Merck board approves additional $5 billion share repurchase program
Merck, known as MSD outside the United States and Canada, today announced that its Board of Directors has approved additional purchases of up to $5 billion of Merck's common stock for its treasury. The treasury stock purchase has no time limit and will be made over time on the open market, in block transactions or in privately negotiated transactions.
Immunovia's new blood-based testing platform accurately detects non-small cell lung cancer
Immunovia AB announced today that in a new collaborative study with a major global pharma company, Immunovia ́s innovative blood-based testing platform, IMMray could differentiate healthy controls from non-small cell lung cancer samples with a 95 % accuracy.
Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer
A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.
Thimerosal to be discussed at Wednesday's CDC meeting
The Advisory Committee on Immunization Practices (ACIP) will meet this week at the CDC in Atlanta. Thimerosal, a controversial mercury-based vaccine preservative, is scheduled to be discussed Wednesday morning at 10:55 am.
› Verified 5 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR
Advanced Practice Midwife